Image of CDC Logo Image containing title: Tuberculosis Information CD-ROM   Image of people
 
1
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

U.S. Department of Health and Human Services logo

Guide for Primary Health Care Providers: Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
2005

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection 2005 PDF

Table of Contents

List of Abbreviations

Introduction
Table 1: Changes Found in the 2000 Guidelines and Subsequent Updates
Table 2: Changes in Terminology

Targeted Tuberculin Testing
Identifying Persons at Risk for Developing TB Disease

Diagnosis of Latent TB Infection
Table 3: Differentiating Between LTBI and TB Disease
Testing for Latent TB infection
Special Considerations in Testing for LTBI
Figure 1: Two-Step Tuberculin Skin Test Method
Classification of Tuberculin Skin Test Reactions
Other Diagnostic Considerations

Treatment of Latent TB Infection
Treatment Regimens
Table 4: Treatment Regimens
Special Considerations in the Treatment of LTBI
Adverse Effects of Drugs Used to Treat LTBI
Patient Monitoring and Education during Treatment
Assessing Adherence
Techniques to Improve Adherence
Posttreatment Follow-Up

Appendix A: Sample TB Risk Assessment Tool
Appendix B: Identifying Persons from High-Risk Countries
Appendix C: Administration and Measurement of the TST
Appendix D: Sample TST and Treatment Documentation Forms

Resources

References

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333